Home › Funds › WELLINGTON MANAGEMENT GROUP LLP › ELV
WELLINGTON MANAGEMENT GROUP LLP position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
WELLINGTON MANAGEMENT GROUP LLP reported holding 9,213,513 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$3.56B, representing 0.68% of its reported portfolio and ranking #20 among its reported holdings. WELLINGTON MANAGEMENT GROUP LLP has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How WELLINGTON MANAGEMENT GROUP LLP's ELV position evolved
WELLINGTON MANAGEMENT GROUP LLP first disclosed a stake in ELV in Q3 2023 at 6,592,766 shares (US$2.87B). The position peaked in Q2 2026 at 9,213,513 shares, worth US$3.56B. Across 12 filings, WELLINGTON MANAGEMENT GROUP LLP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 9,213,513 shares valued at US$3.56B — an increase of 984,976 shares quarter over quarter.. Notable position changes include a 42% increase in Q4 2024 (shares rose 18% over the following quarter), a 25% increase in Q4 2025 (shares fell 16% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.59M | $2.87B | New |
| Q4 2023 | 5.91M | $2.79B | Reduce |
| Q1 2024 | 4.50M | $2.33B | Reduce |
| Q2 2024 | 4.17M | $2.26B | Reduce |
| Q3 2024 | 4.46M | $2.32B | Add |
| Q4 2024 | 6.36M | $2.34B | Add |
| Q1 2025 | 5.79M | $2.52B | Reduce |
| Q2 2025 | 6.32M | $2.46B | Add |
| Q3 2025 | 6.62M | $2.14B | Add |
| Q4 2025 | 8.29M | $2.91B | Add |
| Q1 2026 | 8.23M | $2.41B | Reduce |
| Q2 2026 | 9.21M | $3.56B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 22 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), Sanders Capital, LLC (US$2.25B), Harris Associates (Oakmark) (US$1.90B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.25B · Q2 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- Artisan Partners Limited Partnership 4.58M sh · $1.77B · Q2 2026
- First Eagle Investment Management 4.19M sh · $1.62B · Q2 2026
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2.02M sh · $779.73M · Q2 2026
More on WELLINGTON MANAGEMENT GROUP LLP
FAQ
How long has WELLINGTON MANAGEMENT GROUP LLP held ELV?
WELLINGTON MANAGEMENT GROUP LLP has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is WELLINGTON MANAGEMENT GROUP LLP's current position in ELV?
As of Q2 2026, WELLINGTON MANAGEMENT GROUP LLP holds 9.21M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $3.56B, representing 0.68% of its reported portfolio and ranking #20.
Has WELLINGTON MANAGEMENT GROUP LLP been buying or selling ELV?
In the latest 13F filing (Q2 2026), WELLINGTON MANAGEMENT GROUP LLP increased its position in ELV. The position peaked in Q2 2026 at 9.21M shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, Sanders Capital, LLC, Harris Associates (Oakmark), among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.